Sheryl Gay Stolberg discusses the controversy around hydroxychloroquine, a saga that starkly revealed the collision between science and politics in the midst of the pandemic.

Renee DiResta, a prominent expert who studies malign narratives across social networks, dives into some provocative questions on the different conspiracies surrounding Covid-19.

Steve speaks with Dr. Jean William Pape, a renowned public health professor and practitioner appointed in late April by Haitian President Moïse to co-chair the country’s Covid-19 response commission.

We speak with Professor Salim Abdool Karim (Slim), a preeminent HIV scientist based in Durban to discuss South Africa’s successes and achievements, the acute vulnerabilities of those living with HIV and TB, tough controversies, major constraints, and mistakes that required correction.

Eustace and Carol Theodore describe the uncertain, extended process in discovering Eustace had been infected with Covid-19, after vacationing in England in the first half of March.

In this episode, we are joined by Julien, a wonderfully insightful 13-year-old from Berkeley, California, to talk about his experience of over two months of shelter-in-place.

In this episode, U.S. Senator Chris Van Hollen of Maryland joins us to talk about what Congress can do to respond to Covid-19 right now, including ensuring access and affordability for new treatments and a vaccine, and building stimulus packages for every level of government.

Tulane University professor and historian John Barry, author of the New York Times bestseller "The Great Influenza," discusses the lessons gleaned from the 1918 Spanish Flu pandemic that speak to today’s coronavirus pandemic sweeping America and the world.

We are joined by Director of the Africa CDC Dr. John Nkengasong and U.S. Ambassador to the African Union Jessica Lapenn. Africa CDC is advancing a continental plan to address the dire, burgeoning threat Covid-19 poses to Africa.

In this episode, we bring in CSIS alum Alisha Kramer, who is now practicing obstetrics and gynecology in Atlanta hospitals, to discuss how she assists young pregnant women in navigating the new realities of Covid-19.

​In this episode, the conversation takes off from a recent piece published by Steve and Anna Carroll, Global Health Policy Center’s Associate Fellow, that examines President Trump’s decision to suspend U.S. assistance to the World Health Organization.

In this episode, the hosts are joined by Scott Dowell, coronavirus response leader at the Bill & Melinda Gates Foundation, to discuss how successful the global response has been in saving so many lives, as well as Dr. Dowell's thoughts on which response strategy is best.

As this week marks World Immunization Week, Senior Fellow Katherine Bliss talks to two immunization experts, Angela Shen and Lora Shimp, about the difference between universal health care and coverage, and how including immunizations under a larger package of preventative services means more people benefit for a cheaper cost.

In this episode, Steve and Andrew are joined by Congressman Ami Bera (D-CA07) to talk about his work on the CSIS Commission on Strengthening America’s Health Security and his impressions of Covid-19, as both a doctor and an elected representative.

Former Senator Kelly Ayotte, co-chair of the CSIS Commission on Strengthening America’s Health Security, joins Steve and Andrew in explaining how the Commission’s November 2019 core recommendations remain compelling and essential in the midst of the pandemic, if we are to, once and for all, break the cycle of crisis and complacency.

Peter Sands, executive director of The Global Fund to Fight AIDS, Tuberculosis and Malaria, joins Steve and Andrew in exploring the chasm separating the world of finance and economists from that of public health, the extraordinary threats the pandemic poses to historical gains in development and global health, and the rapidly evolving role of the Global Fund in racing to support partner countries in their response to the coronavirus.

In this episode, Andrew asks Steve to interpret the guidelines issued by President Trump yesterday in a three-phase process of reopening.

Dr. Christopher Murray joins Steve Morrison and Andrew Schwartz to discuss the “Murray Model,” what a rolling reopening of the economy would look like and what that would do to the Murray Model projections, which states may be ready to reopen, and what hotspots he’s worried about most.

In this episode, Susan Glasser, staff writer at The New Yorker, joins Steve and Andrew to discuss the full range of rapidly evolving issues surrounding President Trump and the White House’s engagement with the coronavirus pandemic and the companion economic crisis.

Steve and Andrew are joined by Congresswoman Susan Brooks (R-IN05) to talk about her work on the CSIS Commission on Strengthening America’s Health Security and her experience working through Covid-19.

Ron Klain, former Ebola response coordinator in the Obama Administration, discusses the deep structural changes that are required post-pandemic for America to resume as a global leader, what future observers might conclude on how we reached this treacherous moment, and what gives Ron confidence and hope.

Steve and Andrew speak with Helen Branswell, a premiere journalist and one of the world’s leading experts on dangerous infectious disease outbreaks, based for the past five years at STAT.

Andrew and Steve talk to Dr. Tom Frieden, President and CEO of Resolve to Save Lives and former CDC Director, about the infections and deaths in New York and the risk to healthcare workers, the need for clear federal guidance, and how we can organize to minimize the harm from this pandemic.

Andrew and Steve talk to Secretary John Wiesman on the testing and hospital capacity in Washington state, the scramble for resources that states are finding themselves in and how Washington is working with the private sector to develop these products, and when social distancing might end.

Steve speaks with Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer at Johnson & Johnson, about the unknowns surrounding the COVID-19 virus, the Chinese response, and the role J&J is playing in developing a vaccine.